CHARMD
Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database
English (en)
Français (fr)
Español (es)
CNR Website
Home
Login
Data
All data
Antivirals
Bibliography
Therapeutic targets
Tools
Search
Submit mutations
Request expertise
Genotyping tool
Gene maps
Contact
Notice
How to cite
Last update : Mon 20 Apr 2026
TOP
D542E
Virus:
Human betaherpesvirus 5
Gene:
UL54
Resistance summary:*
Ganciclovir:
No resistance
Cidofovir:
High level resistance
Foscarnet:
No resistance
Cidofovir:
High level resistance
Foscarnet:
No resistance
Ganciclovir:
Intermediate level resistance
*If there is more than one line per antiviral, please refer to the table below
Antiviral assays:
Antiviral
EC50 ratio
Phenotype
Strain
Source
Marker
Assay
Reference
Ganciclovir
1.50
No resistance
Recombinant
Details
Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus. (Jul 2013)
Cidofovir
12.00
High level resistance
Recombinant
Details
Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus. (Jul 2013)
Foscarnet
1.70
No resistance
Recombinant
Details
Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus. (Jul 2013)
Cidofovir
13.00
High level resistance
Laboratory strain, Clinical Isolate
Details
A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
Foscarnet
0.50
No resistance
Laboratory strain, Clinical Isolate
Details
A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
Ganciclovir
3.50
Intermediate level resistance
Laboratory strain, Clinical Isolate
Details
A new locus of foscarnet resistance in the cytomegalovirus UL54 DNA polymerase gene among uncharacterized mutations in recent clinical trials. (Feb 2026)
Tilloy
et al.
, 2024
Interdeposit Digital Number: IDDN.FR.001.420004.000.S.X.2024.000.31230